Assessing real-world safety of plecanatide: a pharmacovigilance study based on the FDA adverse event reporting system
This study preliminarily explores the safety of plecanatide in real-world applications, revealing significant new adverse event signals. These findings provide important safety references for clinicians prescribing plecanatide for CIC and IBS-C.
Authors
- Zhu Li (ORCID: https://orcid.org/0000-0001-6776-8477)
- Yifan Yao
- Zhiyuan Zhang (ORCID: https://orcid.org/0000-0002-9212-8516)
Institutions
- Dalian Medical University (CN)
- Nantong University (CN)
- The Affiliated Taizhou People's Hospital of Nanjing Medical University (CN)
- Nanjing Medical University (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2024-11-25
- DOI
- https://doi.org/10.3389/fphar.2024.1500810
- Citations
- 6
- Primary Topic
- Pharmaceutical studies and practices
- Type
- article
- Field-Weighted Citation Impact
- 6.66